BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21395474)

  • 1. Necessity of level IV dissection in cN0 hypopharyngeal carcinoma.
    Shin YS; Kim SH; Koh YW; Hong HJ; Seol JH; Choi EC
    Acta Otolaryngol; 2011 Jun; 131(6):665-9. PubMed ID: 21395474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC; Lee JS; Choi EC
    Acta Otolaryngol; 2009 Jan; 129(1):57-61. PubMed ID: 18607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it necessary to dissect levels I and IIB in hypopharyngeal cancer?
    Wiegand S; Esters J; Müller HH; Jäcker T; Roessler M; Werner JA; Sesterhenn AM
    Acta Otolaryngol; 2010 Jun; 130(6):747-52. PubMed ID: 19968609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Lohuis PJ; Klop WM; Tan IB; van Den Brekel MW; Hilgers FJ; Balm AJ
    Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic metastases to level IIb in hypopharyngeal squamous cell carcinoma.
    Kim YH; Koo BS; Lim YC; Lee JS; Kim SH; Choi EC
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1060-4. PubMed ID: 17043251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is dissection of levels 4 and 5 justified for cN0 laryngeal and hypopharyngeal cancer?
    Katilmiş H; Oztürkcan S; Ozdemir I; Tuna B; Güvenç IA; Ozkul Y
    Acta Otolaryngol; 2007 Nov; 127(11):1202-6. PubMed ID: 17851904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neck dissection of Levels II and III for the treatment of supraglottic laryngeal cancer with clinically negative neck].
    Jia SS; Wang YY; He HJ; Xiang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):747-50. PubMed ID: 21092673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer].
    Yu WB; Zeng ZY; Chen FJ; Zhang Q; Guo ZM; Li H; Liu XK; Wu GH
    Ai Zheng; 2006 Oct; 25(10):1271-4. PubMed ID: 17059774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level IIb lymph node metastasis in elective neck dissection of oropharyngeal squamous cell carcinoma.
    Lee SY; Lim YC; Song MH; Lee JS; Koo BS; Choi EC
    Oral Oncol; 2006 Nov; 42(10):1017-21. PubMed ID: 16757201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.
    Ferlito A; Silver CE; Rinaldo A
    Laryngoscope; 2008 Apr; 118(4):676-9. PubMed ID: 18182969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck.
    Zhang B; Xu ZG; Tang PZ
    J Surg Oncol; 2006 May; 93(6):464-7. PubMed ID: 16615158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma.
    Lim YC; Lee JS; Koo BS; Choi EC
    Laryngoscope; 2006 Feb; 116(2):268-72. PubMed ID: 16467717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
    Bajwa MS; McMillan R; Khattak O; Thomas M; Krishnan OP; Webster K
    Head Neck; 2011 Mar; 33(3):403-6. PubMed ID: 20629073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.